Immunosuppression_NN
by_IN
glucocorticoids_NNS
:_:
inhibition_NN
of_IN
NF-kappa_NN
B_NN
activity_NN
through_IN
induction_NN
of_IN
I_NN
kappa_NN
B_NN
synthesis_NN
-LCB-_-LRB-
see_VB
comments_NNS
-RCB-_-RRB-

Glucocorticoids_NNS
are_VBP
among_IN
the_DT
most_RBS
potent_JJ
anti-inflammatory_JJ
and_CC
immunosuppressive_JJ
agents_NNS
._.

They_PRP
inhibit_VBP
synthesis_NN
of_IN
almost_RB
all_DT
known_JJ
cytokines_NNS
and_CC
of_IN
several_JJ
cell_NN
surface_NN
molecules_NNS
required_VBN
for_IN
immune_JJ
function_NN
,_,
but_CC
the_DT
mechanism_NN
underlying_VBG
this_DT
activity_NN
has_VBZ
been_VBN
unclear_JJ
._.

Here_RB
it_PRP
is_VBZ
shown_VBN
that_IN
glucocorticoids_NNS
are_VBP
potent_JJ
inhibitors_NNS
of_IN
nuclear_JJ
factor_NN
kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
activation_NN
in_IN
mice_NNS
and_CC
cultured_VBN
cells_NNS
._.

This_DT
inhibition_NN
is_VBZ
mediated_VBN
by_IN
induction_NN
of_IN
the_DT
I_NN
kappa_NN
B_NN
alpha_NN
inhibitory_JJ
protein_NN
,_,
which_WDT
traps_VBZ
activated_VBN
NF-kappa_NN
B_NN
in_IN
inactive_JJ
cytoplasmic_JJ
complexes_NNS
._.

Because_IN
NF-kappa_NN
B_NN
activates_VBZ
many_JJ
immunoregulatory_JJ
genes_NNS
in_IN
response_NN
to_TO
pro-inflammatory_JJ
stimuli_NNS
,_,
the_DT
inhibition_NN
of_IN
its_PRP$
activity_NN
can_MD
be_VB
a_DT
major_JJ
component_NN
of_IN
the_DT
anti-inflammatory_JJ
activity_NN
of_IN
glucocorticoids_NNS
._.

